Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies (Q33369463)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies |
scientific article |
Statements
1 reference
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies (English)
1 reference
Owen A O'Connor
1 reference
Steven Horwitz
1 reference
Mark L Heaney
1 reference
Lawrence Schwartz
1 reference
Stacie Richardson
1 reference
Robert Willim
1 reference
Barbara MacGregor-Cortelli
1 reference
Tracey Curly
1 reference
Craig Moskowitz
1 reference
Carol Portlock
1 reference
Stanley Frankel
1 reference
Victoria Richon
1 reference
Paul Marks
1 reference
William K Kelly
1 reference
5 December 2005
1 reference
1 reference
24
1 reference
166-173
1 reference
Identifiers
1 reference
1 reference